Preinfusion risk factors for the development of severe neurotoxicity following CART therapy in pediatric patients.
Saved in:
| Title: | Preinfusion risk factors for the development of severe neurotoxicity following CART therapy in pediatric patients. |
|---|---|
| Authors: | Diorio C; Division of Oncology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States.; Department of Pediatrics Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania United States., Myers RM; Division of Oncology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States.; Department of Pediatrics Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania United States., Li Y; Division of Oncology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States., Liu H; Division of Oncology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States.; Department of Pediatrics Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania United States., Belfer S; Division of Neurology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States.; Department of Neurology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania United States., DiNofia A; Division of Oncology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States.; Department of Pediatrics Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania United States., Leahy AB; Division of Oncology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States.; Department of Pediatrics Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania United States., Newman H; Division of Oncology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States.; Department of Pediatrics Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania United States., Dolan J; Division of Oncology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States., Martinez Z; Division of Oncology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States., Elhachimi A; Division of Oncology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States., Lindell RB; Division of Critical Care Medicine at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States.; Department of Anesthesiology and Critical Care Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania United States., Mullen C; Division of Oncology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States., Li A; Division of Oncology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States., Kim J; Division of Oncology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States., Teachey DT; Division of Oncology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States.; Department of Pediatrics Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania United States., Maude SL; Division of Oncology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States.; Department of Pediatrics Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania United States., Grupp SA; Division of Oncology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States.; Department of Pediatrics Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania United States., McGuire JL; Department of Pediatrics Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania United States.; Division of Neurology at the Children's Hospital of Philadelphia Philadelphia Pennsylvania United States.; Department of Neurology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania United States. |
| Source: | HemaSphere [Hemasphere] 2026 Apr 08; Vol. 10 (4), pp. e70337. Date of Electronic Publication: 2026 Apr 08 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2572-9241 |
|---|---|
| DOI: | 10.1002/hem3.70337 |
